Uploaded on Jan 29, 2024
According to the latest research report by IMARC Group, The global male infertility market size reached US$ 4.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 6.2 Billion by 2032, exhibiting a growth rate (CAGR) of 4.79% during 2024-2032. More Info:- https://www.imarcgroup.com/male-infertility-market
Male Infertility Market Growth, Demand and Challenges of the Key Industry Players 2024-2032
Global Male Infertility Market Research and Forecast Report 2024- 2032 Format: PDF+EXCEL © 2023 IMARC All Rights Reserved About IMARC Group In ternat ional Market Analys is Research and Consul t ing Group is a leading adv iser on management s t rategy and market research wor ldwide. We par tner wi th c l ients in a l l regions and indust ry vert ica ls to ident i fy thei r h ighest -value oppor tuni t ies, address thei r most cr i t ica l chal lenges, and t ransform thei r bus inesses. IMARC’s in format ion products inc lude major market , sc ient i f ic , economic and technological developments for bus iness leaders in pharmaceut ica l , indust r ia l , and h igh technology organizat ions. Market forecasts and indust ry analys is for b iotechnology, advanced mater ia ls , chemicals , food and beverage, t ravel and tour ism, nanotechnology and novel process ing methods are at the top of the company’s exper t ise. IMARC’s ta i lored approach combines unfathomable ins ight in to the dynamics o f companies and markets wi th c lose cooperat ion at a l l levels of the c l ient organizat ion. This ensures that our c l ients achieve unmatchable compet i t ive advantage, bui ld more pro f ic ient organizat ions, and secure las t ing resul ts . A cc o r d i ng t o t h e l a t e s t r e p o r t b y IM A R C Gr o u p , t i t l e d " Ma l e In f e r t i l i t y M a rk e t : G l o b a l I n d u s t r y T re n d s , S h a re , S i z e , Gr o w th , O p p o r t u n i ty an d F o r e ca s t 2 0 2 4 - 20 3 2 , " t h e g l o b a l m a l e i n fe r t i l i t y m a r ke t s i z e r e a c he d U S $ 4 . 0 B i l l i o n i n 2 0 2 3 . Ma l e i n f e r t i l i t y r e f e r s t o a me d i c a l c o n d i t i on w h e r e i n a ma n e x p e r i e n c es d i f f i cu l t i e s i n Report i mp r e g na t i n g a f e r t i l e f em a l e p a r t ne r , r e s u l t i n g i n t he i n ab i l i t y o r r e d u ce d l i k e l i h o od o f co n c e i v i n g a ch i l d . I t i s c a u se d d u e t o v a r i o u s f a c to r s , i n c l ud i n g l o w s p e rm c o u n t , p o o r sp e r m mo t i l i t y , ab n o r ma l s p e r m m o r ph o l o g y , ho r m on a l i m ba l a n c e s , g e n e t i c d i s o r d e r s , Highlight and t e s t i c u l a r d a m ag e , a nd b l o ck a g e s i n t h e r e p ro d u c t i v e s y s te m . I t s t r e a t me n t i nv o l v e s e v a l u a t i n g s e me n pa r a m e t e r s , s u ch a s s p e r m c o u n t , mo t i l i t y , a n d mo r p h o l o g y , as s e s s i n g h o r m o n a l p r o f i l e s , a n d c o n d uc t i n g s p e c i a l i ze d t e s t s , l i k e Description ge n e t i c s c r e en i n g , h o r mo n e t e s t i n g , a n d i ma g i n g s t ud i e s . B e s i d e s t h i s , i t c a n a l so b e t re a t e d u s i ng h o r m on a l t h e ra p y , s u rg i c a l p r oc e d u re s t o c o r r ec t b l o ck a g e s a n d ab n o r m a l i t i e s , a nd a s s i s t ed r e p r od u c t i v e t e c h no l o g i e s , s u c h a s i n v i t r o f e r t i l i z a t i o n ( IV F ) a nd i n t ra c y t op l as m i c s p e r m i n j e c t i o n ( I C S I ) . R eq u e s t f o r a P D F sa m p l e o f t h i s re p o r t : h t t p s : / /w w w . i ma r c g r o u p . co m / ma l e - i n fe r t i l i t y - ma r k e t / r e qu e s t s a mp l e Report Description G l o b a l M a l e I n f e r t i l i t y M a r k e t T r e n d s : T h e i n c r e a s i n g p r e v a l e n c e o f m a l e i n f e r t i l i t y a r o u n d t h e w o r l d d u e t o c h a n g i n g l i f e s t y l e s , s t r e s s , p o o r n u t r i t i o n , e x p o s u r e t o e n v i r o n m e n t a l t o x i n s , a n d a g i n g r e p r e s e n t s o n e o f t h e s i g n i f i c a n t f a c t o r s p r o p e l l i n g t h e m a r k e t g r o w t h . A d d i t i o n a l l y , t h e r i s i n g a w a r e n e s s a m o n g i n d i v i d u a l s a b o u t i n f e r t i l i t y i s s u e s a n d t h e i n c r e a s i n g a c c e p t a n c e o f t r e a t m e n t s , p r o m p t e d b y r e d u c e d s o c i e t a l s t i g m a , a r e d r i v i n g t h e d e m a n d f o r m a l e i n f e r t i l i t y s o l u t i o n s . T h e r i s i n g d e m a n d f o r p e r s o n a l i z e d a n d p r e c i s i o n m e d i c i n e i n i n f e r t i l i t y t r e a t m e n t i s a l s o c o n t r i b u t i n g t o m a r k e t g r o w t h . M o r e o v e r , a d v a n c e m e n t s i n d i a g n o s t i c p r o c e d u r e s a n d t h e r i s i n g a d o p t i o n o f t r e a t m e n t s l i k e a s s i s t e d r e p r o d u c t i v e t e c h n o l o g i e s ( A R T ) a n d i n - v i t r o f e r t i l i z a t i o n a r e f u r t h e r b o l s t e r i n g t h e g r o w t h o f t h e m a r k e t . T h e a d v e n t o f c u t t i n g - e d g e t e c h n o l o g i e s i n s p e r m a n a l y s i s a n d t h e d e v e l o p m e n t o f n o v e l d r u g t h e r a p i e s a r e o f f e r i n g p r o m i s i n g m a r k e t g r o w t h o p p o r t u n i t i e s t o i n d u s t r y i n v e s t o r s . F u r t h e r m o r e , g o v e r n m e n t i n i t i a t i v e s p r o m o t i n g f e r t i l i t y t r e a t m e n t a n d i n c r e a s e d i n v e s t m e n t i n r e s e a r c h a n d d e v e l o p m e n t ( R & D ) a r e i m p e l l i n g t h e m a r k e t g r o w t h . T h e i n t r o d u c t i o n o f s u p p o r t i v e p o l i c i e s , s u c h a s i n s u r a n c e c o v e r a g e f o r i n f e r t i l i t y t r e a t m e n t s a n d r e i m b u r s e m e n t o p t i o n s , i s e n c o u r a g i n g i n d i v i d u a l s a n d c o u p l e s t o s e e k m e d i c a l a s s i s t a n c e f o r m a l e i n f e r t i l i t y . L o o k i n g f o r w a r d , t h e m a r k e t v a l u e i s p r o j e c t e d t o r e a c h U S $ 6 . 2 B i l l i o n b y 2 0 3 2 , e x p a n d i n g a t a C A G R o f 4 . 7 9 % d u r i n g 2 0 2 4 - 2 0 3 2 . V i e w R e p o r t T O C , F i g u r e s a n d T a b l e s : h t t p s : / / w w w . i m a r c g r o u p . c o m / m a l e - i n f e r t i l i t y - m a r k e t Breakup by Type: • Sperm Agglut inat ion • DNA Fragmentat ion Technique • Oxidat ive Stress Analys is • Computer Assisted Semen Analysis • Sperm Penetrat ion Assay • Others Report Segmentation Breakup by Treatment: • Medicat ion • Assisted Reproduct ive Technology and Var icoce le Surgery Breakup by Distribution Channel: • Hospita ls Pharmacies • Pharmacies and Drug Stores • Onl ine Pharmacies Breakup by End User: • Hospita ls and Cl inics • Fert i l i ty Centers • Research Inst i tutes Report • Others Segmentation Breakup by Region: • North America • Europe • Asia-Pacifi c • Lat in America • Middle East and Afr ica • Andrology Solut ions • CinnaGen Co. • Halotech DNA Competitive • SCSA Diagnostics Inc. Landscape • Vitrol i fe with Key • Zydus Lifesciences Limited • Intas Pharmaceuticals Ltd. Players • Endo International plc. What was the size of the global male infertility market in 2023? What is the expected growth rate of the global male infertility market during 2024-2032? Key What are the key factors driving the global Questions male infertility market? Answered in What has been the impact of COVID-19 on the global male infertility market? the Report What is the breakup of the global male infertility market based on the test type? What is the breakup of the global male infertility market based on the treatment? What is the breakup of the global male infertility market based on the distribution channel? What is the breakup of the global male infertility market based on the end user? Key Questions What are the key regions in the global male infertility market? Answered in Who are the key players/companies in the the Report global male infertility market? 1 P r e f a c e 2 S c o p e a n d M e t h o d o l o g y 2 . 1 O b j e c t i v e s o f t h e S t u d y 2 . 2 S t a k e h o l d e r s 2 . 3 D a t a S o u r c e s 2 . 3 . 1 P r i m a r y S o u r c e s 2 . 3 . 2 S e c o n d a r y S o u r c e s 2 . 4 M a r k e t E s t i m a t i o n Table of 2 . 4 . 1 B o t t o m - U p A p p r o a c h 2 . 4 . 2 T o p - D o w n A p p r o a c h 2 . 5 F o r e c a s t i n g M e t h o d o l o g y 3 E x e c u t i v e S u m m a r y 4 I n t r o d u c t i o n Contents 4 . 1 O v e r v i e w 4 . 2 K e y I n d u s t r y T r e n d s5 G l o b a l M a l e I n f e r t i l i t y M a r k e t 5 . 1 M a r k e t O v e r v i e w 5 . 2 M a r k e t P e r f o r m a n c e 5 . 3 I m p a c t o f C O V I D - 1 9 5 . 4 M a r k e t F o r e c a s t 6 M a r k e t B r e a k u p b y T e s t T y p e 6 . 1 S p e r m A g g l u t i n a t i o n 6 . 1 . 1 M a r k e t T r e n d s 6 . 1 . 2 M a r k e t F o r e c a s t 6 . 2 D N A F r a g m e n t a t i o n T e c h n i q u e 6 . 2 . 1 M a r k e t T r e n d s 6 . 2 . 2 M a r k e t F o r e c a s t 6 . 3 O x i d a t i v e S t r e s s A n a l y s i s 6 . 3 . 1 M a r k e t T r e n d s 6 . 3 . 2 M a r k e t F o r e c a s t 6 . 4 C o m p u t e r A s s i s t e d S e m e n A n a l y s i s 6 . 4 . 1 M a r k e t T r e n d s 6 . 4 . 2 M a r k e t F o r e c a s t 6 . 5 S p e r m P e n e t r a t i o n A s s a y 6 . 5 . 1 M a r k e t T r e n d s 6 . 5 . 2 M a r k e t F o r e c a s t 6 . 6 O t h e r s 6 . 6 . 1 M a r k e t T r e n d s 6 . 6 . 2 M a r k e t F o r e c a s t Table of 7 M a r k e t B r e a k u p b y T r e a t m e n t 7 . 1 M e d i c a t i o n 7 . 1 . 1 M a r k e t T r e n d s 7 . 1 . 2 M a r k e t F o r e c a s t Contents 7 . 2 A s s i s t e d R e p r o d u c t i v e T e c h n o l o g y a n d V a r i c o c e l e S u r g e r y 7 . 2 . 1 M a r k e t T r e n d s 7 . 2 . 2 M a r k e t F o r e c a s t 8 M a r k e t B r e a k u p b y D i s t r i b u t i o n C h a n n e l 8 . 1 H o s p i t a l s P h a r m a c i e s 8 . 1 . 1 M a r k e t T r e n d s 8 . 1 . 2 M a r k e t F o r e c a s t 8 . 2 P h a r m a c i e s a n d D r u g S t o r e s 8 . 2 . 1 M a r k e t T r e n d s 8 . 2 . 2 M a r k e t F o r e c a s t 8 . 3 O n l i n e P h a r m a c i e s 8 . 3 . 1 M a r k e t T r e n d s 8 . 3 . 2 M a r k e t F o r e c a s t F o r m o r e i n f o r m a t i o n , v i s i t : ht t ps : / /w ww. i ma rc gro up . c o m /m a l e - i n fe r t i l i t y -m a rke t / t o c Disclaimer © 2023 IMARC Al l R ights Reserved Th is Pub l i ca t ion and a l l i t ’ s con ten ts un less o therw ise men t i oned a re copy r i gh ted in the name o f I n t e rna t i ona l Marke t Ana lys i s Research and Consu l t ing ( IMARC) . No pa r t o f t h i s pub l i ca t ion may be rep roduced , repackaged , red i s t r i bu ted o r res o ld i n who le o r i n any pa r t . The pub l i ca t ion may a l so no t be used i n any f o rm o r by and means g raph i c e lec t ron ic o r mechan ic a l , i nc lud ing pho tocopy ing , reco rd ing , t ap ing o r by i n fo rmat i on s to rage o r re t r ieva l , o r by any o the r f o rm, w i t hou t the exp ress c ons en t o f I n t e rna t iona l Marke t Ana lys i s Research and Consu l t i ng ( IMARC) . Disc la imer : Al l con ten ts and da ta o f t h i s pub l i c a t i on , i nc lud ing fo recas t s , da ta ana lys i s and op in ion have been based on in f o rmat ion and sources be l ieved to be accu ra te and re l iab le a t t he t ime o f pub l i sh ing . In t e rna t i ona l Ma rke t Ana l ys is Research and Consu l t ing makes no rep resen ta t ion o f war ran t y o f any k ind as to t he acc u racy o r comp le teness o f any I n fo rmat i on p rov ided . IMARC accep ts no l i ab i l i t y wha tsoever f o r any los s o r damage resu l t i ng f rom op in ion , e r ro rs o r i naccu rac ies i f any f ound th is pub l i ca t ion . IMARC, IMARC Group and G loba l Therapy I ns igh t Ser i es a re reg is t e red t rademarks o f I n te rna t iona l Marke t Ana lys i s Research and Consu l t ing . A l l o the r t rademarks used i n th i s pub l i ca t i on a re reg i s te red t rademarks o f t he i r r espec t i ve compan ies . Contact Us Visit us at : https://www.imarcgroup.com TELEPHONE: +1-631-791-1145 E-MAIL: [email protected]
Comments